Tian, G., Courtney, A. N., Jena, B., Heczey, A., Liu, D., Marinova, E., . . . Metelitsa, L. S. (2016). CD62L(+) NKT cells have prolonged persistence and antitumor activity in vivo. J Clin Invest.
Chicago Style CitationTian, Gengwen, et al. "CD62L(+) NKT Cells Have Prolonged Persistence and Antitumor Activity in Vivo." J Clin Invest 2016.
Cita MLATian, Gengwen, et al. "CD62L(+) NKT Cells Have Prolonged Persistence and Antitumor Activity in Vivo." J Clin Invest 2016.
Atenció: Aquestes cites poden no estar 100% correctes.